Metraipolis › archive › dc_ccddf538cd2a

Treatment of heterotopic ossification via inhibiting the MMP-2/CDH5 axis through oral delivery of network pharmacology-predicted Chinese medicine — Europe PMC PMID:42099999

Source: Europe PMC (en)
Original: https://europepmc.org/article/MED/42099999
DOI: 10.1016/j.mtbio.2026.103107
License (as archived): solo-consultazione
Archived: 2026-10-08T07:02:42.071Z
SHA-256 of the archived text: 1489b9fd11274a0ab06d62cb5ee30cd16ca01965d76a6c066cc5d619b5af414e
Stable URL of this page: https://metraipolis.com/documento/dc_ccddf538cd2a

How to cite

Treatment of heterotopic ossification via inhibiting the MMP-2/CDH5 axis through oral delivery of network pharmacology-predicted Chinese medicine — Europe PMC PMID:42099999 — Europe PMC (en), https://europepmc.org/article/MED/42099999 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_ccddf538cd2a (Metraipolis archive dc_ccddf538cd2a, sha256 1489b9fd11274a0ab06d62cb5ee30cd16ca01965d76a6c066cc5d619b5af414e)

BibTeX

@misc{dcccddf538cd2a,
  title = {Treatment of heterotopic ossification via inhibiting the MMP-2/CDH5 axis through oral delivery of network pharmacology-predicted Chinese medicine — Europe PMC PMID:42099999},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42099999},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_ccddf538cd2a; sha256 1489b9fd11274a0ab06d62cb5ee30cd16ca01965d76a6c066cc5d619b5af414e},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42099999. Agents can read the archived copy with the MCP tool read_document.